A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk is under pressure from investors for more information about its next-generation ...

The practices in the intervention group received interactive training and were provided a software programme to assist with individual dose adjustment. The control group performed usual care.